Matrix Metalloproteinase Inhibitors and Cancer—Trials and TribulationsLisa M. Coussens, Lynn M. Matrisian, Barbara Fingleton|Science|2002Cited by 2.7k
Matrix Metalloproteinases: Biologic Activity and Clinical ImplicationsAmy R. Nelson, Lynn M. Matrisian, Barbara Fingleton et al.|Journal of Clinical Oncology|2000Cited by 1.6k
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesisYang Li, P. Charles Lin, Laura M. DeBusk et al.|Cancer Cell|2004Cited by 1.1k
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1Veerle Noë, Marc Mareel, Barbara Fingleton et al.|Journal of Cell Science|2001Cited by 688
The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumorsHoward C. Crawford, Lynn M. Matrisian, Paul Polakis et al.|Oncogene|1999Cited by 670